First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac
Tomas Janssen, K. Aitken, Filippo Alongi, Aisling Barry, Uffe Bernchou, Simon Boeke, William A. Hall, Ali Hosni, P.S. Kroon, Marcel Nachbar, Hina Saeed, Ina M. Jürgenliemk‐Schulz, Tine Schytte, Helena M. Verkooijen, Marlies E. Nowee
Abstract
The treatment of oligometastatic disease using MR guidance is an evolving field. Since August 2018 patients are treated on a 1.5 Tesla MR-Linac (MRL). We present current workflows and practice standards from seven institutions for the initial patients treated for lymph node and liver metastases.
Topics & Concepts
SABR volatility modelMedicineLinear particle acceleratorLymph nodeRadiologyMedical physicsInternal medicineOpticsPhysicsBeam (structure)Financial economicsEconomicsVolatility (finance)Stochastic volatilityAdvanced Radiotherapy TechniquesMedical Imaging Techniques and ApplicationsLung Cancer Diagnosis and Treatment